Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience

The transgenic adenocarcinoma of mouse prostate (TRAMP) mouse is a well‐studied murine model of prostate cancer with histopathology and disease progression that mimic the human disease. To investigate differences in cellular bioenergetics between normal prostate epithelial cells and prostate tumor cells, in vivo MR spectroscopic (MRS) studies with non‐proton nuclei, such as 13C, in the TRAMP model would be extremely useful. The recent development of a method for retaining dynamic nuclear polarization (DNP) in solution permits high signal‐to‐noise ratio (SNR) 13C MRI or MRSI data to be obtained following injection of a hyperpolarized 13C agent. In this transgenic mouse study, this method was applied using a double spin‐echo (DSE) pulse sequence with a small‐tip‐angle excitation RF pulse, hyperbolic‐secant refocusing pulses, and a flyback echo‐planar readout trajectory for fast (10–14 s) MRSI of 13C pyruvate (pyr) and its metabolic products at 0.135 cm3 nominal spatial resolution. Elevated 13C lactate (lac) was observed in both primary and metastatic tumors, demonstrating the feasibility of studying cellular bioenergetics in vivo with DNP hyperpolarized 13C MRSI. Magn Reson Med, 2007. © 2007 Wiley‐Liss, Inc.

[1]  R. Franklin,et al.  Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer , 1998, The Prostate.

[2]  D. Leibfritz,et al.  Fast proton spectroscopic imaging with high signal‐to‐noise ratio: Spectroscopic RARE , 2002, Magnetic resonance in medicine.

[3]  L. Melstrom,et al.  Malignancy. , 1938, California and western medicine.

[4]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[6]  Jan H. Ardenkjær-Larsen,et al.  Molecular imaging with endogenous substances , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Nelson.  Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors , 2001, Magnetic resonance in medicine.

[9]  C Hawryszko,et al.  Design and evaluation of a novel dual-tuned resonator for spectroscopic imaging , 1990 .

[10]  A Macovski,et al.  A reduced power selective adiabatic spin‐echo pulse sequence , 1991, Magnetic resonance in medicine.

[11]  J Kurhanewicz,et al.  Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[12]  M. Thaning,et al.  Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Z. Hall.  Cancer , 1906, The Hospital.

[14]  J. Kurhanewicz,et al.  Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer , 2001, Cancer investigation.

[15]  F A Jolesz,et al.  Gradient-echo imaging considerations for hyperpolarized 129Xe MR. , 1996, Journal of magnetic resonance. Series B.

[16]  John M Pauly,et al.  Design of flyback echo‐planar readout gradients for magnetic resonance spectroscopic imaging , 2005, Magnetic resonance in medicine.

[17]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[18]  Lars E Olsson,et al.  Hyperpolarized 13C MR angiography using trueFISP , 2003, Magnetic resonance in medicine.

[19]  Gioacchino Tedeschi,et al.  High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.

[20]  A. Heerschap,et al.  Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. , 1993, The Journal of urology.

[21]  W Dreher,et al.  A new method for fast proton spectroscopic imaging: Spectroscopic GRASE , 2000, Magnetic resonance in medicine.

[22]  J. VanMeter,et al.  In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate Cancer Models , 2006, The Prostate.

[23]  Tsuey-Ming Chen,et al.  Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.

[24]  L DelaBarre,et al.  The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.

[25]  L Zhao,et al.  Gradientecho imaging considerations for hyperpolarized ^ Xe MR , 1996 .

[26]  R. Franklin,et al.  Bioenergetic theory of prostate malignancy , 1994, The Prostate.